Tellworth British Recovery & Growth

BRIT will be a new UK focussed ‘All-Cap’ trust with stock-picking by the highly experienced Paul Marriage and team at Tellworth Investments…

Disclosure – Non-Independent Marketing Communication

This is a non-independent marketing communication commissioned by Tellworth British Recovery & Growth. The report has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibition on the dealing ahead of the dissemination of investment research.

Tellworth British Recovery & Growth

Disclosure – Non-Independent Marketing Communication

This is a non-independent marketing communication commissioned by Tellworth British Recovery & Growth Trust plc. The report has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibition on the dealing ahead of the dissemination of investment research.

Tellworth British Recovery & Growth Trust plc (BRIT) is a new investment trust which will sit in the AIC UK All Companies sector. It aims to benefit from the investment manager’s view that UK equities are out of favour on an international basis, offering an opportunity to stock picking investors who are willing to take a long-term view.

Tellworth is a relatively new fund management company set up by Paul Marriage and John Warren in 2017 following successful careers first at Cazenove and then Schroders where they ran popular open-ended funds. This new trust will seek to use the advantages of the closed-ended structure to invest in a portfolio designed for the market conditions of today.

This portfolio will be relatively concentrated with 35-45 stocks. The managers will have a flexible mandate to invest in companies large and small, and not follow any particular benchmark. That said, they are restricting themselves to companies which have a significant presence in the UK, and will not be investing in mining, energy and gas or biotechnology companies.

The illustrative portfolio will be made up of three different buckets identified by the manager – with c. 40% in British Global Leaders, 40% in British Recovery and 20% in British Technology (for more information please see Portfolio). The team will be investing in what they think offers the best long-term returns, and the trust structure will allow them to run winners for longer, but also invest in less liquid opportunities. The manager has permission to invest up to 10% of the trust’s portfolio in unlisted companies which clearly adds to the potential opportunity set, but might also add to risks.

Given the target makeup of the portfolio, BRIT will be relatively balanced between ‘growth’ and ‘value’ stocks. As such, the managers believe BRIT represents a good “all-weather” option. The shares are expected to start trading on 13 October.

Analyst's View

In our view, Paul Marriage and the team at Tellworth are one of the key selling points of BRIT. As we discuss in the Performance section, the team have a long-term track record of successfully generating alpha and adding value for their investors through their stock picking approach to UK equities. The trust structure should aid them in continuing this track record, allowing the managers to run winners longer and access less liquid opportunities.

At the same time, there are risks. The trust has the potential to be geared up to 25% of NAV, and the portfolio will also be more concentrated than would be the case for an open-ended fund. With these factors taken into account, we believe it is fair to assume that the portfolio volatility will be higher than the historic track record suggests (see Performance).

Investors who participate in the IPO of BRIT will be purchasing shares on a premium of c. 1.75%. Compared to the UK All Companies sector which has an average discount of 12% currently, at launch BRIT will be at a significant premium to peers. There are a number of discount control features built into the structure, but it remains to be seen how the board and manager would deal with the discount widening out. However, in our view, there are enough precedents of trusts maintaining a significant premium to their AIC peer group if they offer a differentiated proposition and good relative performance.

bull bear
Access to Paul Marriage and team's stock picking prowess within a closed-ended structure Concentrated portfolio and gearing may add to volatility of the strategy
Flexible mandate and focussed approach should allow managers to generate significant alpha Illiquid investments (listed and unlisted) may prove hard to realise in order for the board to manage any discount that appears
Differentiated trust offering interesting balanced approach to UK based companies COVID-19 and Brexit negotiations may yet cause a recession and/or market volatility over the short term
William Heathcoat Amory
William Heathcoat Amory is a co-founding partner of Kepler Partners LLP and leads the Kepler investment trust research team. William has 18 years of experience as an investment company analyst. Prior to co-founding Kepler Partners in 2008, he was part of the Extel number 1 rated research team at JPMorgan Cazenove.

Disclaimer

This report has been issued by Kepler Partners LLP.  The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.  

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm’s internal rules. A copy of the firm’s Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 9/10 Savile Row, London W1S 3PF with registered number OC334771.

Welcome to Kepler Trust Intelligence

Kepler Trust Intelligence is authorised in the UK by the Financial Conduct Authority.
Please enter a valid email address
{{item.msg}}
Please enter a valid password
{{item.msg}}
Please enter a valid email address
{{item.msg}}
Please check your email. If an account exists you'll be sent instructions on how to reset your password.
Kepler Trust Intelligence is authorised in the UK by the Financial Conduct Authority. To ensure that we are able to provide content which is appropriate for you, please tell us a little about yourself.
Please choose an option
{{item.msg}}
Please enter a company name
{{item.msg}}
Please enter a location name
{{item.msg}}
Please choose an option
{{item.msg}}
Please enter a platform
{{item.msg}}
Please choose an option
{{item.msg}}
Please enter a trust
{{item.msg}}
?
The information contained herein is not for distribution and does not constitute an offer to sell or the solicitation of any offer to buy any securities in the United States to or for the benefit of any United States person (being residents of the United States or partnerships or corporations organised under the laws thereof). The investment funds referred to herein have not been registered in the United States under the Investment Company Act of 1940 and units or shares of such funds are not registered in the United States under the Securities Act of 1933.
Please confirm
{{item.msg}}
Please select an option
{{item.msg}}
See benefits
A free Kepler Trust Intelligence account allows you to access premium content including the ‘Kepler View’ – our verdict on the trusts we cover – and historical research so you can see how our view has changed over time. An account also unlocks useful facilities like the ‘follow’ button which lets you keep track of the trusts you’re interested in and as a logged in user you can also download PDFs of our research, and choose the layout of the page you’re reading to suit your preference. We will not share your details unless you give us permission to do so, and we won’t bombard you with emails – we only send one a week.
Please select an option
{{item.msg}}
Please enter your first name
{{item.msg}}
Please enter your last name
{{item.msg}}
Please enter a valid email address
An account already exists with this email - have you forgotten your password?
{{item.msg}}
Please enter a valid password
{{item.msg}}
Please enter a valid password
{{item.msg}}
Your answers help us to tailor our content to relevant investment trusts, and to ensure that the asset allocation and portfolio strategy research we produce is appropriate to our userbase. We do not share your personal information and your answers are not linked to your identity for marketing purposes.
Need help?

One more thing...

Did you know, you can 'follow' individual trusts on Kepler Trust Intelligence? Use the functions below to set up alerts and we'll send you research and updates on your chosen trusts.

Suggested trusts to follow

Browse all funds
Need help?
Current Site Kepler Trust Intelligence is produced by the investment companies team at Kepler Partners and is the UK’s premier source of detailed qualitative research on investment trusts. Absolute Hedge is a market leading UCITS research database providing proprietary research on funds, themes and strategies in the UCITS space. Kepler Liquid Strategies is a Dublin domiciled UCITS fund platform featuring a number of best-of-breed fund managers. Kepler Partners is a corporate advisory and asset raising boutique specialising in the regulated funds market in Europe and investment trusts in the UK.